| Name | Eptinezumab |
|---|
| Description | Eptinezumab is a human monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. Eptinezumab can be used for the prevention of migraine in adults[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Dhillon S. Eptinezumab: First Approval. Drugs. 2020;80(7):733-739. |
| No Any Chemical & Physical Properties |